JP6253059B2 - エンドトキシン吸着材 - Google Patents
エンドトキシン吸着材 Download PDFInfo
- Publication number
- JP6253059B2 JP6253059B2 JP2014518702A JP2014518702A JP6253059B2 JP 6253059 B2 JP6253059 B2 JP 6253059B2 JP 2014518702 A JP2014518702 A JP 2014518702A JP 2014518702 A JP2014518702 A JP 2014518702A JP 6253059 B2 JP6253059 B2 JP 6253059B2
- Authority
- JP
- Japan
- Prior art keywords
- polymer
- adsorbent
- present
- solution
- negative charge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002158 endotoxin Substances 0.000 title claims description 210
- 239000003463 adsorbent Substances 0.000 title claims description 96
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 192
- 229920000858 Cyclodextrin Polymers 0.000 claims description 189
- 229920000642 polymer Polymers 0.000 claims description 143
- 239000003431 cross linking reagent Substances 0.000 claims description 71
- 238000000034 method Methods 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 30
- 125000000524 functional group Chemical group 0.000 claims description 29
- 239000000758 substrate Substances 0.000 claims description 29
- 239000013076 target substance Substances 0.000 claims description 29
- 230000001747 exhibiting effect Effects 0.000 claims description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 150000007523 nucleic acids Chemical class 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 19
- 238000005349 anion exchange Methods 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 230000003100 immobilizing effect Effects 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 239000000243 solution Substances 0.000 description 73
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- 238000001179 sorption measurement Methods 0.000 description 33
- 239000000126 substance Substances 0.000 description 26
- 239000002904 solvent Substances 0.000 description 25
- 239000002585 base Substances 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000002245 particle Substances 0.000 description 22
- 238000004132 cross linking Methods 0.000 description 18
- 239000012948 isocyanate Substances 0.000 description 17
- 150000002513 isocyanates Chemical class 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 11
- 229910002027 silica gel Inorganic materials 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000003446 ligand Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- -1 DNA at the same time Chemical class 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 238000005342 ion exchange Methods 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 239000012528 membrane Substances 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- 150000004804 polysaccharides Chemical class 0.000 description 7
- 230000035484 reaction time Effects 0.000 description 7
- 108010039918 Polylysine Proteins 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000001450 anions Chemical class 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000005341 cation exchange Methods 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 150000002009 diols Chemical class 0.000 description 5
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 241000239218 Limulus Species 0.000 description 3
- 108010040201 Polymyxins Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000002952 polymeric resin Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229920000083 poly(allylamine) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009841 combustion method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical group C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940124508 injectable medicine Drugs 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical group O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000011140 membrane chromatography Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- JXUKBNICSRJFAP-UHFFFAOYSA-N triethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](OCC)(OCC)CCCOCC1CO1 JXUKBNICSRJFAP-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3042—Use of binding agents; addition of materials ameliorating the mechanical properties of the produced sorbent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3085—Chemical treatments not covered by groups B01J20/3007 - B01J20/3078
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
- B01J20/3282—Crosslinked polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/64—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63
- C08G18/6484—Polysaccharides and derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/52—Sorbents specially adapted for preparative chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
[1]
以下の特徴(1)〜(4)を有する、シクロデキストリンのポリマー:
(1)下記式1に示すN/C=6〜15である;
N/C(モル%)=窒素含有量(モル)÷炭素含有量(モル)×100 ・・・(式1)
(2)シクロデキストリンの水酸基の一部がウレタン結合を形成している;
(3)水に不溶性である;
(4)陰イオン交換容量が0.1meq/g未満である。
[2]
シクロデキストリンと架橋剤を反応させることを含む、前記ポリマーの製造方法であって、
前記架橋剤が、分子当たり、1またはそれ以上のイソシアネート基と、水酸基と反応しうる1またはそれ以上の官能基を有する化合物である、方法。
[3]
前記水酸基と反応しうる官能基がイソシアネート基である、前記方法。
[4]
基材と、該基材に固定化された前記ポリマーとを含む、エンドトキシン吸着材。
[5]
前記ポリマーを基材へ固定化することを含む、前記エンドトキシン吸着材の製造方法。
[6]
基材、シクロデキストリン、および架橋剤を反応させることを含む、前記エンドトキシン吸着材の製造方法であって、
前記架橋剤が、1またはそれ以上のイソシアネート基と、水酸基と反応しうる1またはそれ以上の官能基を有する化合物である、方法。
[7]
前記水酸基と反応しうる官能基がイソシアネート基である、前記方法。
[8]
前記ポリマーまたは前記吸着材と、マイナスチャージを示す目的物質およびエンドトキシンを含有する溶液を接触させることを含む、エンドトキシンを除去する方法。
[9]
前記ポリマーまたは前記吸着材と、マイナスチャージを示す目的物質およびエンドトキシンを含有する溶液とを接触させることを含む、エンドトキシンの除去されたマイナスチャージを示す目的物質を含有する溶液の製造方法。
[10]
前記マイナスチャージを示す目的物質が核酸である、前記方法。
[11]
前記核酸がDNAである、前記方法。
[12]
前記核酸がRNAである、前記方法。
(1)炭素原子に対して、モル比で6%〜15%の窒素原子を含有する;
(2)シクロデキストリンの水酸基の一部がウレタン結合を形成している;
(3)水に不溶性である;
(4)実質的に陰イオン交換能を示さない。
N/C(モル%)=窒素含有量(モル)÷炭素含有量(モル)×100 ・・・(式1)
膨潤度(wet−mL/dry−g)=測定体積(mL)/乾燥重量(g) ・・・(式3)
<1−1>実施例1〜18のCDポリマーの合成
架橋剤としてエピクロロヒドリン(クロロメチルオキシラン(CMO)ともいう)を用いた以外は、実施例1〜18のCDポリマーの合成と同様の手順で、比較例1〜3のCDポリマーを合成した。用いたCDの種類と添加量および架橋剤の種類と添加量を表3に示す。
上記で得られたCDポリマーにおけるイソシアネート基の導入量は、CDポリマーを減圧乾燥した後、元素分析により求めた。CDは窒素原子を有していないため、測定された窒素分は架橋剤のイソシアネート基に由来するものである。結果を表4に示す。
上記で得られたCDポリマーの陰イオン交換容量は、pH滴定法によって定量した。まずCDポリマー5mlをガラスフィルター上に移し、メタノール、アセトン、およびエーテルで順に洗浄後、24時間減圧乾燥した。得られた乾燥CDポリマー0.5gを秤量し、100mlの三角フラスコに入れ、0.1N−塩酸水溶液を正確に25ml加えた。2時間攪拌後、反応液を100mlのメスフラスコにろ取し、蒸留水で100mlに定容した。この希釈液から25mlを分取し、0.05N−水酸化ナトリウムを用い、フェノールフタレインを指示薬として滴定した。滴定は3回繰り返し、平均値を陰イオン交換容量の算出に用いた。陰イオン交換容量(AEC)は下記式2により求めた。結果を表5に示す。併せて、市販のET吸着材であるセルファインETクリーンL(JNC株式会社製)およびデトキシゲル(Detoxi-Gel;サーモフィッシャー/ピアス製)の陰イオン交換容量も示す。
AEC(meq/g)=(0.1×fHCl×VHCl−0.05×fNaOH×VNaOH×100/25)÷W ・・・(式2)
fHCl:0.1N-塩酸水溶液のファクター
fNaOH:0.05N-水酸化ナトリウム水溶液のファクター
VHCl:0.1N-塩酸の添加量(ml)
VNaOH:0.05N-水酸化ナトリウム水溶液の滴定量(ml)
W:乾燥CDポリマーの重量(g)
体積として3mL−6mL程度の量のCDポリマーを10mLメスシリンダーに入れた。体積値が安定するまで、静置とタッピングを繰り返し、その体積を測定した。次に、体積を測定したメスシリンダー中のCDポリマーを20mLのビーカーに全て回収し、80℃で16時間以上放置し水分を蒸発させてCDポリマーを乾燥させた後に、CDポリマーの乾燥重量を測定した。膨潤度を下記式3により求めた。結果を表5に示す。
膨潤度(wet−mL/dry−g)=測定体積(mL)/乾燥重量(g) ・・・(式3)
<5−1>ETフリー化
ET吸着量の測定に供するCDポリマーおよび市販のET吸着材のETフリー化を以下の手順で行った。上記で得られたCDポリマー、ならびに市販のET吸着材であるデトキシゲル(サーモフィッシャー/ピアス製)およびセルファインETクリーンL(JNC株式会社製)のそれぞれを5−10g秤量し、滅菌済みのガラスフィルター上で洗浄液(0.2M NaOHを含む95%エタノール溶液)50mLで5回洗浄を繰り返した。次に、洗浄後のサンプルを100mL用フラスコに入れ、洗浄液を50mL添加し、25℃、1時間、200rpmで撹拌した。次に、撹拌後のサンプルをガラスフィルター上で再び洗浄液25mLで5回洗浄し、さらに、注射用蒸留水を用いてろ液が中性になるまで洗浄を繰り返した後、イオン強度0.05のリン酸バッファー(pH6)で平衡化し、ETフリー化済みの吸着材として以降の実験に用いた。
E.coli O55-B5株由来LPSを所定量含むイオン強度0.05のリン酸バッファー(pH6)をサンプル溶液として用いて、以下の手順でET吸着除去試験を行った。上記で得られたETフリー化済みの吸着材0.1gを20mL三角フラスコに入れ、サンプル液を2mL加え、4℃、200rpmで1時間撹拌した。得られた懸濁溶液をシリンジで吸い取り、0.8μmメンブランフィルターでろ過した。得られたろ過液中の残存エンドキシン濃度を定量した。ET濃度の測定は、市販のキット(リムルスES−IIテスト和光、和光純薬製)を用いて行った。
サンプル溶液として、E.coli O55-B5株由来LPSを15EU/mL、鮭白子由来DNAを50mg/mL含むイオン強度が0.05から0.8のリン酸バッファー(pH6)を用いて、<5−2>と同様の手順でET吸着除去試験を行った。得られた処理液(ろ過液)中の残存エンドキシン濃度および残存DNA濃度を定量し、イオン強度とETの選択的吸着量の関係を調べた。ET濃度の測定は、<5−2>と同様に行った。DNA濃度は、260nmの吸光度に基づいて測定した。
サンプル溶液として、E.coli O55-B5株由来LPSを15EU/mL、鮭白子由来DNAを50mg/mL含むイオン強度が0.05でpHが4から9の緩衝液(下記)を用いて、<5−2>と同様の手順でET吸着除去試験を行った。得られた処理液(ろ過液)中の残存エンドキシン濃度および残存DNA濃度を定量し、pHとETの選択的吸着量の関係を調べた。ET濃度の測定は、<5−2>と同様に行った。DNA濃度は、260nmの吸光度に基づいて測定した。
<用いた緩衝液>
pH4、5 酢酸緩衝液(CH3COOH−CH3COONa)
pH6、7 リン酸緩衝液(Na2HPO4−NaH2PO4)
pH8、9 トリス緩衝液(Tris−HCl)
多孔質シリカゲル20g(粒径30μm、平均細孔径1300Å)を、3−グリシドキシプロピルトリエトキシシラン20gおよびトリエチルアミン5mLに懸濁し、8時間還流させた。冷却後、シリカゲルをトルエン400mL、メタノール400mL、純水1L、アセトン400mL、およびメタノール400mLの順で洗浄し、80℃で真空乾燥して、エポキシ導入シリカゲルを26g得た。エポキシ導入シリカゲル20gを、0.7%過酸化水素水900mL及びアセトニトリル100mLに懸濁し、6時間還流させた。冷却後、シリカゲルをトルエン400mL、メタノール400mL、純水1L、アセトン400mL、メタノール400mLの順で洗浄し80℃で真空乾燥して、ジオール含有シリカゲル15gを得た。70mlのDMF溶液に5gのγCDを徐々に加えて溶解させた。得られたCD溶液を500mLの三つ口フラスコに入れ、70℃で10分撹拌した。同フラスコに架橋剤であるHMDI2.5gを加えた後、70℃、200rpmで30分間撹拌した。その後、ジオール含有シリカ10gを加え、70℃、200rpmで4時間攪拌した。得られた生成物をガラスフィルター(G3)上に移し、純水を用いてDMF臭が完全になくなるまで洗浄および吸引ろ過を繰り返し、実施例19の吸着材を得た。吸着材は95%メタノール中に保存した。
特開昭53−86749に記載の方法で製造されたセルロース粒子(平均粒径およそ100μm、排除限界分子量およそ2500−3500)20g湿重量(乾燥重量で約10g)を80℃で乾燥させ、乾燥セルロース粒子を得た。70mlのDMF溶液に5gのγCDを徐々に加えて溶解させた。得られたCD溶液を500mLの三つ口フラスコに入れ、70℃で10分撹拌した。同フラスコに架橋剤であるHMDI4gを加えた後、70℃、200rpmで30分間撹拌した。その後、乾燥セルロース粒子10gを加え、70℃、200rpmで4時間攪拌した。得られた生成物をガラスフィルター(G3)上に移し、純水を用いてDMF臭が完全になくなるまで洗浄および吸引ろ過を繰り返し、実施例20の吸着材を得た。吸着材は95%メタノール中に保存した。
70mlのDMF溶液に5gのγCDを徐々に加えて溶解させた。得られたCD溶液を500mLの三つ口フラスコに入れ、70℃で10分撹拌した。同フラスコに架橋剤であるHMDI4gを加えた後、70℃、200rpmで30分間撹拌した。その後、セファデックッスG−25(粒径およそ85−260μm、排除限界分子量5000以上、GEヘルスケアバイオサイエンス株式会社)10g(乾燥重量)を加え、70℃、200rpmで4時間攪拌した。得られた生成物をガラスフィルター(G3)上に移し、純水を用いてDMF臭が完全になくなるまで洗浄および吸引ろ過を繰り返し、実施例21の吸着材を得た。吸着材は95%メタノール中に保存した。
特開昭55−44312に記載の方法で製造されたセルロース粒子(平均粒径およそ100μm、排除限界分子量200万以上)100g湿重量(乾燥重量で約10g)に、γCD10gを溶解させた純水100mLを加えて、よく混合した。得られた懸濁液をエバポレーターで減圧乾固させて、乾燥物を得た。この乾燥物19gに200mLのジオキサンを加えて、30℃で1時間、200rpmで攪拌した。その後、温度を80℃に上昇させ、架橋剤としてHMDI9gを加えて、更に4時間攪拌した。得られた生成物をガラスフィルター(G3)上に移し、純水を用いてDMF臭が完全になくなるまで洗浄および吸引ろ過を繰り返し、実施例22の吸着材を得た。吸着材は95%メタノール中に保存した。
実施例2のCDポリマー0.1gを乳鉢で粉砕して粒径がおよそ0.1〜1μmのCDポリマー粒子を調製し、DMF50mLに懸濁した。得られた懸濁液をNo5Cのろ紙(φ6cm)がセットされたフィルターホルダー(テフロン(登録商標)製)に循環し、ろ紙にCDポリマー粒子を保持させた。循環液にほとんどCDポリマー粒子がなくなった後に、温度を80℃に上昇させ、架橋剤としてHMDI1gを加え、4時間循環を継続した。液の循環を中止し、メタノール100mL、純水100mLを順次流して洗浄し、実施例23の吸着材を得た。吸着材は95%メタノール中に保存した。
<11−1>カラムクロマトグラフィーによるET除去
10mL容量のカラムに実施例19〜22の吸着材のそれぞれを1mL充填し、洗浄液(0.2M NaOHを含む95%エタノール水溶液)を10mL通液させ、その後3時間洗浄液に浸漬した。その後、洗浄液をさらに10mL通液した後、注射用蒸留水を50mL通液した。次いで、ETフリーの0.2Mリン酸バッファー(pH7)を5mL通液しカラムを平衡化した。
実施例23の吸着材(CDポリマーの固定化されたろ紙)をセットしたフィルターホルダーに洗浄液(0.2M NaOHを含む95%エタノール水溶液)を10mL通液させ、その後3時間洗浄液に浸漬した。その後、洗浄液をさらに10mL通液した後、注射用蒸留水を50mL通液した。次いで、ETフリーの0.2Mリン酸バッファー(pH7)を5mL通液し平衡化した。
Claims (10)
- 基材と、該基材に固定化された以下の特徴(1)〜(4)を有する、シクロデキストリンのポリマーとを含む、エンドトキシン吸着材。
(1)下記式1に示すN/C=6〜15である;
N/C(モル%)=窒素含有量(モル)÷炭素含有量(モル)×100 ・・・(式1)
(2)シクロデキストリンの水酸基の一部がウレタン結合を形成している;
(3)水に不溶性である;
(4)陰イオン交換容量が0.1meq/g未満である。 - 以下の特徴(1)〜(4)を有する、シクロデキストリンのポリマーを基材へ固定化することを含む、請求項1に記載のエンドトキシン吸着材の製造方法。
(1)下記式1に示すN/C=6〜15である;
N/C(モル%)=窒素含有量(モル)÷炭素含有量(モル)×100 ・・・(式1)
(2)シクロデキストリンの水酸基の一部がウレタン結合を形成している;
(3)水に不溶性である;
(4)陰イオン交換容量が0.1meq/g未満である。 - 基材、シクロデキストリン、および架橋剤を反応させることを含む、請求項1に記載のエンドトキシン吸着材の製造方法であって、
前記架橋剤が、1またはそれ以上のイソシアネート基と、水酸基と反応しうる1またはそれ以上の官能基を有する化合物である、方法。 - 前記水酸基と反応しうる官能基がイソシアネート基である、請求項3に記載の方法。
- 請求項1に記載の吸着材と、マイナスチャージを示す目的物質およびエンドトキシンを含有する溶液を接触させることを含む、エンドトキシンを除去する方法。
- 請求項1に記載の吸着材と、マイナスチャージを示す目的物質およびエンドトキシンを含有する溶液とを接触させることを含む、エンドトキシンの除去されたマイナスチャージを示す目的物質を含有する溶液の製造方法。
- 前記マイナスチャージを示す目的物質が核酸である、請求項5または6に記載の方法。
- 前記核酸がDNAである、請求項7に記載の方法。
- 前記核酸がRNAである、請求項7に記載の方法。
- 前記溶液のpHが4〜6である、請求項5〜9のいずれか一項に記載の方法。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014518702A JP6253059B2 (ja) | 2012-05-30 | 2013-05-29 | エンドトキシン吸着材 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012123281 | 2012-05-30 | ||
| JP2012123281 | 2012-05-30 | ||
| JP2014518702A JP6253059B2 (ja) | 2012-05-30 | 2013-05-29 | エンドトキシン吸着材 |
| PCT/JP2013/064905 WO2013180176A1 (ja) | 2012-05-30 | 2013-05-29 | エンドトキシン吸着材 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2013180176A1 JPWO2013180176A1 (ja) | 2016-01-21 |
| JP6253059B2 true JP6253059B2 (ja) | 2017-12-27 |
Family
ID=49673364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014518702A Expired - Fee Related JP6253059B2 (ja) | 2012-05-30 | 2013-05-29 | エンドトキシン吸着材 |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US9505850B2 (ja) |
| JP (1) | JP6253059B2 (ja) |
| WO (1) | WO2013180176A1 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6424343B2 (ja) * | 2014-09-02 | 2018-11-21 | 国立大学法人 熊本大学 | エンドトキシン吸着剤 |
| JP6956407B2 (ja) * | 2015-04-20 | 2021-11-02 | コーネル ユニバーシティ | 多孔性シクロデキストリン高分子材料及びそれを製造する方法並びに使用する方法 |
| JP7002712B2 (ja) | 2017-07-06 | 2022-01-20 | 国立大学法人信州大学 | エンドトキシンの検出方法および検出装置 |
| CN107413317B (zh) * | 2017-08-16 | 2020-02-14 | 江苏理工学院 | 壳聚糖改性gma/maa聚合物吸附剂及其方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6011961B2 (ja) | 1982-03-31 | 1985-03-29 | 工業技術院長 | ポリシクロデキストリンビ−ズの製法 |
| CA1221307A (en) | 1982-12-02 | 1987-05-05 | Nobutaka Tani | Adsorbent and process for preparing the same |
| JPS59193135A (ja) | 1983-04-18 | 1984-11-01 | Kanegafuchi Chem Ind Co Ltd | 吸着体 |
| JPS6011961A (ja) | 1983-06-30 | 1985-01-22 | Fujitsu Ltd | プロセツサの制御方式 |
| JPS6020924A (ja) | 1983-07-14 | 1985-02-02 | Agency Of Ind Science & Technol | ビ−ズ状不溶性シクロデキストリンポリマ−の製法 |
| US4917956A (en) * | 1988-07-11 | 1990-04-17 | Uop | Method of preparing cyclodextrin-coated surfaces |
| JPH03296516A (ja) * | 1990-04-16 | 1991-12-27 | Uop Inc | シクロデキストリン被覆の固体基体 |
| JPH04256438A (ja) | 1991-02-06 | 1992-09-11 | Chuichi Hirayama | 発熱物質吸着剤 |
| JP2995274B2 (ja) | 1991-06-06 | 1999-12-27 | 工業技術院長 | コーヒー抽出液の呈味改良方法 |
| DE59505786D1 (de) | 1994-02-07 | 1999-06-02 | Qiagen Gmbh | Verfahren zur abreicherung oder entfernung von endotoxinen |
| JP2001504879A (ja) * | 1996-11-22 | 2001-04-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | シクロデキストリンポリマー分離材 |
| JPH10195108A (ja) | 1997-01-09 | 1998-07-28 | Makoto Komiyama | 架橋シクロデキストリン高分子の合成方法と、該高分子によるコレステロールの除去 |
| JP3817808B2 (ja) | 1997-02-17 | 2006-09-06 | 東レ株式会社 | 液体処理用カラムおよび液体処理方法 |
| JP2000189792A (ja) | 1998-12-29 | 2000-07-11 | Masashi Funayama | リポ多糖吸着体およびリポ多糖の吸着除去方法。 |
| JP4996791B2 (ja) | 2001-03-14 | 2012-08-08 | Jnc株式会社 | エンドトキシン吸着体、及びそれを用いたエンドトキシンの除去方法 |
| JP2003226755A (ja) | 2002-02-04 | 2003-08-12 | Maeda Seikan Kk | 不溶性シクロデキストリン誘導体及びこれを用いた環境ホルモン除去材 |
| JP4225731B2 (ja) | 2002-02-04 | 2009-02-18 | 前田製管株式会社 | シクロデキストリン架橋体及びこれを用いた環境ホルモン除去材 |
| JP4683632B2 (ja) * | 2004-08-20 | 2011-05-18 | 明和化成株式会社 | 球状シクロデキストリンポリマー、その製造方法及びそれが含まれた吸着剤 |
| JP4888879B2 (ja) | 2004-11-24 | 2012-02-29 | 地方独立行政法人青森県産業技術センター | ビーズ状シクロデキストリンポリマー製造方法 |
| EP1752171A1 (en) * | 2005-07-28 | 2007-02-14 | Istituto Clinico Humanitas | Haemofilters for blood detoxification |
| EP1945675A1 (en) * | 2005-09-09 | 2008-07-23 | Avery Dennison Corporation | Hydrogel including modified cyclodextrin crosslinked with polyurethane prepolymer |
| JP5017848B2 (ja) | 2005-11-25 | 2012-09-05 | Jnc株式会社 | エンドトキシン吸着体、およびそれを用いたエンドトキシンの除去方法 |
-
2013
- 2013-05-29 US US14/404,479 patent/US9505850B2/en not_active Expired - Fee Related
- 2013-05-29 WO PCT/JP2013/064905 patent/WO2013180176A1/ja not_active Ceased
- 2013-05-29 JP JP2014518702A patent/JP6253059B2/ja not_active Expired - Fee Related
-
2016
- 2016-10-04 US US15/285,465 patent/US10155217B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2013180176A1 (ja) | 2016-01-21 |
| US20150112050A1 (en) | 2015-04-23 |
| US10155217B2 (en) | 2018-12-18 |
| US20170021332A1 (en) | 2017-01-26 |
| WO2013180176A1 (ja) | 2013-12-05 |
| US9505850B2 (en) | 2016-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9522365B2 (en) | Cross-linked cellulose membranes | |
| Ahmad et al. | Adsorption of heavy metal ions: role of chitosan and cellulose for water treatment | |
| JP6467652B2 (ja) | エンドトキシン吸着剤 | |
| ES2945064T3 (es) | Membrana híbrida que comprende celulosa entrecruzada | |
| US8496123B2 (en) | Process for cross-linking cellulose ester membranes | |
| JP6764464B2 (ja) | 多孔性架橋セルロースゲル及びその製造方法 | |
| EP3050902A1 (en) | Method for producing porous cellulose beads using alkali aqueous solution, carrier for ligand immobilization, and adsorbent | |
| Huang et al. | Heparin-like chitosan hydrogels with tunable swelling behavior, prolonged clotting times, and prevented contact activation and complement activation | |
| US8445427B2 (en) | Endotoxin adsorbent, and method for removing endotoxin using the same | |
| JP6253059B2 (ja) | エンドトキシン吸着材 | |
| JP6424343B2 (ja) | エンドトキシン吸着剤 | |
| EP3284778A1 (en) | Method for producing porous cellulose beads, and adsorbent using same | |
| CN102653596A (zh) | 硝酸纤维素膜表面交联壳聚糖改性材料的制备方法 | |
| WO2015056681A1 (ja) | 多孔質セルロースビーズの製造方法およびそれを用いた吸着体 | |
| CN103933947B (zh) | 用于清除类风湿因子的血液净化材料及其制备方法 | |
| JP2021178270A (ja) | エンドトキシン吸着剤及びその製造方法 | |
| Yu et al. | Adsorption of bilirubin by amine-containing crosslinked chitosan resins | |
| JP2005281372A (ja) | 不溶性シクロデキストリン担持高分子成形物の製造法 | |
| JPH03290188A (ja) | 酵素もしくは微生物固定化用担体の製造方法 | |
| JPH05161710A (ja) | 体液浄化用吸着材料の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160202 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160202 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170131 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170329 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170531 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20171024 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20171121 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6253059 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |